Presented on April 20, 2020 by Dr. Roberto Caporali
During this 1-hour webinar, Dr. Caporali will share his experiences with Canadian rheumatologists; he will discuss how the management of rheumatic patients has been impacted by the COVID-19 pandemic and the relevancy of anti-rheumatic drugs as possible therapies for the coronavirus disease.
At the end of this session, participants will be able to:
- discuss best practices for the management of rheumatic patients during the COVID-19 pandemic
- describe anti-rheumatic drugs as possible therapies for COVID-19
- recognize COVID-19, cytokines and severe acute respiratory syndrome
- Medical Expert
This webinar is part of a series supported by unrestricted educational grants from CRA COVID-19 Response Webinar Series supporters.